BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28247082)

  • 1. Membrane pressures predict clotting of pediatric continuous renal replacement therapy circuits.
    Kakajiwala A; Jemielita T; Hughes JZ; Windt K; Denburg M; Goldstein SL; Laskin B
    Pediatr Nephrol; 2017 Jul; 32(7):1251-1261. PubMed ID: 28247082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT).
    Brophy PD; Somers MJ; Baum MA; Symons JM; McAfee N; Fortenberry JD; Rogers K; Barnett J; Blowey D; Baker C; Bunchman TE; Goldstein SL
    Nephrol Dial Transplant; 2005 Jul; 20(7):1416-21. PubMed ID: 15855212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional citrate anticoagulation for continuous renal replacement therapy in children.
    Rico MP; Fernández Sarmiento J; Rojas Velasquez AM; González Chaparro LS; Gastelbondo Amaya R; Mulett Hoyos H; Tibaduiza D; Quintero Gómez AM
    Pediatr Nephrol; 2017 Apr; 32(4):703-711. PubMed ID: 27896442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond the randomized clinical trial: citrate for continuous renal replacement therapy in clinical practice.
    Tovey L; Dickie H; Gangi S; Terblanche M; McKenzie C; Beale R; Treacher D; Ostermann M
    Nephron Clin Pract; 2013; 124(1-2):119-23. PubMed ID: 24281234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citrate and low-dose heparin combined anticoagulation in pediatric continuous renal replacement therapy.
    Zhu D; He J; Xiao Z; Zhou X; Zhang X
    Sci Rep; 2024 Jun; 14(1):13504. PubMed ID: 38866989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children.
    Raymakers-Janssen PAMA; Lilien M; van Kessel IA; Veldhoen ES; Wösten-van Asperen RM; van Gestel JPJ
    Pediatr Nephrol; 2017 Oct; 32(10):1971-1978. PubMed ID: 28578542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial.
    Stucker F; Ponte B; Tataw J; Martin PY; Wozniak H; Pugin J; Saudan P
    Crit Care; 2015 Mar; 19(1):91. PubMed ID: 25881975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.
    Gattas DJ; Rajbhandari D; Bradford C; Buhr H; Lo S; Bellomo R
    Crit Care Med; 2015 Aug; 43(8):1622-9. PubMed ID: 25853591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting circuit life during continuous renal replacement therapy in children with liver failure.
    Goonasekera CD; Wang J; Bunchman TE; Deep A
    Ther Apher Dial; 2015 Feb; 19(1):16-22. PubMed ID: 25195689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. We Use Heparin as the Anticoagulant for CRRT.
    Karakala N; Tolwani A
    Semin Dial; 2016 Jul; 29(4):272-4. PubMed ID: 27082940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous renal replacement therapy in COVID-19-associated AKI: adding heparin to citrate to extend filter life-a retrospective cohort study.
    Valle EO; Cabrera CPS; Albuquerque CCC; Silva GVD; Oliveira MFA; Sales GTM; Smolentzov I; Reichert BV; Andrade L; Seabra VF; Lins PRG; Rodrigues CE
    Crit Care; 2021 Aug; 25(1):299. PubMed ID: 34412667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
    Bagshaw SM; Laupland KB; Boiteau PJ; Godinez-Luna T
    J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure.
    Rodriguez K; Srivaths PR; Tal L; Watson MN; Riley AA; Himes RW; Desai MS; Braun MC; Akcan Arikan A
    PLoS One; 2017; 12(8):e0182134. PubMed ID: 28792509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dialysis circuit clotting in critically ill patients with COVID-19 infection.
    Khoo BZE; Lim RS; See YP; Yeo SC
    BMC Nephrol; 2021 Apr; 22(1):141. PubMed ID: 33879086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous renal replacement therapy (CRRT) in patients with liver disease: is circuit life different?
    Agarwal B; Shaw S; Shankar Hari M; Burroughs AK; Davenport A
    J Hepatol; 2009 Sep; 51(3):504-9. PubMed ID: 19615775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous Renal Replacement Therapy in Venovenous Extracorporeal Membrane Oxygenation: A Retrospective Study on Regional Citrate Anticoagulation.
    Giani M; Scaravilli V; Stefanini F; Valsecchi G; Rona R; Grasselli G; Bellani G; Pesenti AM; Foti G
    ASAIO J; 2020 Mar; 66(3):332-338. PubMed ID: 31045918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Filter Size Not the Anticoagulation Method is the Decisive Factor in Continuous Renal Replacement Therapy Circuit Survival.
    Miklaszewska M; Korohoda P; Zachwieja K; Kobylarz K; Stefanidis CJ; Sobczak A; Drożdż D
    Kidney Blood Press Res; 2017; 42(2):327-337. PubMed ID: 28578343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citrate anticoagulation for continuous renal replacement therapy in small children.
    Soltysiak J; Warzywoda A; Kociński B; Ostalska-Nowicka D; Benedyk A; Silska-Dittmar M; Zachwieja J
    Pediatr Nephrol; 2014 Mar; 29(3):469-75. PubMed ID: 24337319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
    Morabito S; Guzzo I; Solazzo A; Muzi L; Luciani R; Pierucci A
    J Nephrol; 2003; 16(4):566-71. PubMed ID: 14696760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.